Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Z. Chen; J. E. Cortes; J. L. Jorgensen; W. Wang; C. C. Yin; M. J. You; E. Jabbour; H. M. Kantarjian; L. J. Medeiros; S. Hu

doi:10.1038/leu.2016.6

Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Z. Chen
, J. E. Cortes
, J. L. Jorgensen
, W. Wang
, C. C. Yin
, M. J. You
, E. Jabbour
, H. M. Kantarjian
, L. J. Medeiros
, S. Hu

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1606-1609
Number of pages	4
Journal	Leukemia
Volume	30
Issue number	7
DOIs	https://doi.org/10.1038/leu.2016.6
State	Published - Jul 1 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2016.6

Cite this

Chen, Z., Cortes, J. E., Jorgensen, J. L., Wang, W., Yin, C. C., You, M. J., Jabbour, E., Kantarjian, H. M., Medeiros, L. J., & Hu, S. (2016). Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia, 30(7), 1606-1609. https://doi.org/10.1038/leu.2016.6

Chen, Z, Cortes, JE, Jorgensen, JL, Wang, W, Yin, CC, You, MJ, Jabbour, E, Kantarjian, HM, Medeiros, LJ & Hu, S 2016, 'Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy', Leukemia, vol. 30, no. 7, pp. 1606-1609. https://doi.org/10.1038/leu.2016.6

@article{5ecf941eefcf484a84ce542469dc74c2,

title = "Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy",

author = "Z. Chen and Cortes, \{J. E.\} and Jorgensen, \{J. L.\} and W. Wang and Yin, \{C. C.\} and You, \{M. J.\} and E. Jabbour and Kantarjian, \{H. M.\} and Medeiros, \{L. J.\} and S. Hu",

year = "2016",

month = jul,

day = "1",

doi = "10.1038/leu.2016.6",

language = "English (US)",

volume = "30",

pages = "1606--1609",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "7",

}

TY - JOUR

T1 - Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

AU - Chen, Z.

AU - Cortes, J. E.

AU - Jorgensen, J. L.

AU - Wang, W.

AU - Yin, C. C.

AU - You, M. J.

AU - Jabbour, E.

AU - Kantarjian, H. M.

AU - Medeiros, L. J.

AU - Hu, S.

PY - 2016/7/1

Y1 - 2016/7/1

UR - https://www.scopus.com/pages/publications/84958817965

UR - https://www.scopus.com/pages/publications/84958817965#tab=citedBy

U2 - 10.1038/leu.2016.6

DO - 10.1038/leu.2016.6

M3 - Letter

C2 - 26837843

AN - SCOPUS:84958817965

SN - 0887-6924

VL - 30

SP - 1606

EP - 1609

JO - Leukemia

JF - Leukemia

IS - 7

ER -

Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this